SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-033633
Filing Date
2021-06-21
Accepted
2021-06-21 16:26:55
Documents
5
Period of Report
2021-06-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cccc-8k_20210615.htm 8-K 60135
2 EX-99.1 cccc-ex991_8.htm EX-99.1 30884
3 EX-99.2 cccc-ex992_9.htm EX-99.2 9019
4 GRAPHIC gleue10vdsx5000001.jpg GRAPHIC 7489
5 GRAPHIC gp1fnctcyo5p000001.jpg GRAPHIC 10304
  Complete submission text file 0001564590-21-033633.txt   126051
Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39567 | Film No.: 211030931
SIC: 2836 Biological Products, (No Diagnostic Substances)